Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Motzer RJ, Bander NH, Nanus DM: Renal-cell carcinoma [see comment]. N Engl J Med 335:865–875, 1996.
Figlin RA: Renal cell carcinoma: management of advanced disease. J Urol 161:381–166, 1999; discussion 386–387.
Zekri J, Ahmed N, Coleman RE, et al.: The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 19:379–382, 2001.
Motzer RJ, Mazumdar M, Bacik J, et al.: Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17:2530–2540, 1999.
Fertil B, Malaise EP: Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11:1699–1707, 1985.
Deschavanne PJ, Fertil B: A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 34:251–266, 1996.
Lee J, Hodgson D, Chow E, et al.: A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer 104:1894–1900, 2005.
Fossa SD, Kjolseth I, Lund G: Radiotherapy of metastases from renal cancer. Eur Urol 8:340–342, 1982.
Halperin EC, Harisiadis L: The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 51:614–617, 1983.
DiBiase SJ, Valicenti RK, Schultz D, et al.: Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol 158:746–749, 1997.
Onufrey V, Mohiuddin M: Radiation therapy in the treatment of metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys 11:2007–2009, 1985.
Seitz W, Karcher KH, Binder W: Radiotherapy of metastatic renal cell carcinoma. Sem Surg Oncol 4:100–102, 1988.
Bayley A, Milosevic M, Blend R, et al.: A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma. Cancer 92:303–310, 2001.
Arcangeli G, Micheli A, Giannarelli D, et al.: The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol 14:95–101, 1989.
Jensen NH, Roesdahl K: Single-dose irradiation of bone metastases. Acta Radiol Ther Phys Biol 15:337–339, 1976.
Schocker JD, Brady LW: Radiation therapy for bone metastasis. Clin Orthopaed Related Res 169:38–43, 1982.
Vargha ZO, Glicksman AS, Boland J: Single-dose radiation therapy in the palliation of metastatic disease. Radiology 93:1181–1184, 1969.
Brinkmann OA, Bruns F, Prott FJ, et al.: Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC). Anticancer Res 19:1583–1587, 1999.
Huguenin PU, Kieser S, Glanzmann C, et al.: Radiotherapy for metastatic carcinomas of the kidney or melanomas: an analysis using palliative end points. Int J Radiat Oncol Biol Phys 41:401–405, 1998.
Redman BG, Hillman GG, Flaherty L, et al.: Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma. Clin Cancer Res 4:283–286, 1998.
Price P, Hoskin PJ, Easton D, et al.: Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 6:247–255, 1986.
Hoskin PJ, Price P, Easton D, et al.: A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 23:74–78, 1992.
Steenland E, Leer JW, van Houwelingen H, et al.: The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. [see comment] [Erratum appears in Radiother Oncol 1999 Nov;53(2):167.] Radiother Oncol 52:101–109, 1999.
Niewald M, Tkocz HJ, Abel U, et al.: Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys 36:1085–1089,1996.
Nielsen OS, Bentzen SM, Sandberg E, et al.: Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 47:233–240, 1998.
Jeremic B, Shibamoto Y, Acimovic L, et al.: A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 42:161–167, 1998.
8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 52:111–121, 1999.
Gaze MN, Kelly CG, Kerr GR, et al.: Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 45:109–116, 1997.
Duncan G, Duncan W, Maher EJ: Patterns of palliative radiotherapy in Canada. Clin Oncol (Royal College of Radiologists) 5:92–97, 1993.
Chow E, Danjoux C, Wong R, et al.: Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. [see comment] Radiother Oncol 56:305–314,2000.
Ben-Josef E, Shamsa F, Williams AO, et al.: Radiotherapeutic management of osseous metastases: a survey of current patterns of care. Int J Radiat Oncol Biol Phys 40:915–921, 1998.
Bentzen SM, Hoskin P, Roos D, et al.: Fractionated radiotherapy for metastatic bone pain: evidence-based medicine or...? [comment] Int J Radiat Oncol Biol Phys 46:681–683, 2000.
Salazar OM, Rubin P, Hendrickson FR, et al.: Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 58:29–36, 1986.
Kuban DA, Delbridge T, el-Mahdi AM, et al.: Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate. J Urol 141:572–574, 1989.\balance
Fitzpatrick PJ, Rider WD: Half body radiotherapy. Int J Radiat Oncol Biol Phys 1:197–207, 1976.
Hoskin PJ, Ford HT, Harmer CL: Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patients. Clin Oncol (Royal College of Radiologists) 1:67–69, 1989.
Quilty PM, Kirk D, Bolger JJ, et al.: A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 31:33–40, 1994.
Van Dyk J, Keane TJ, Kan S, et al.: Radiation pneumonitis following large single dose irradiation: a re-evaluation based on absolute dose to lung. Int J Radiat Oncol Biol Phys 7:461–467, 1981.
Salazar OM, Sandhu T, da Motta NW, et al.: Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). [see comment] Int J Radiat Oncol Biol Phys 50:765–775, 2001.
Zelefsky MJ, Scher HI, Forman JD, et al.: Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens. Int J Radiat Oncol Biol Phys 17:1281–1285, 1989.
Bauman G, Charette M, Reid R, et al.: Radiopharmaceuticals for the palliation of painful bone metastasis—-a systemic review. Radiother Oncol 75:258–270, 2005.
Finlay IG, Mason MD, Shelley M: Radioisotopes for the palliation of metastatic bone cancer: a systematic review. [see comment]. Lancet Oncol 6:392–400, 2005.
Wersall PJ, Blomgren H, Lax I, et al.: Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 77:88–95, 2005.
Loizzi M, Sollitto F, Sardelli P, et al.: Endothoracic nodules in patients who under-went nephrectomy for renal cell carcinoma. Results of surgical resection. Minerva Med 94:103–110, 2003.
Kavolius JP, Mastorakos DP, Pavlovich C, et al.: Resection of metastatic renal cell carcinoma. J Clin Oncol 16:2261–2266, 1998.
Pohlman B, Sweetenham J, Macklis RM: Review of clinical radioimmunotherapy. Expert Rev Anticancer Ther 6:445–461, 2006.
Ling CC, Yorke E, Fuks Z: From IMRT to IGRT: frontierland or neverland? Radiother Oncol 78:119–122, 2006.
Fuks Z, Kolesnick R: Engaging the vascular component of the tumor response. Cancer Cell 8:89–91, 2005.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Warde, P.R., Gospodarowicz, M.K. (2008). Radiotherapy. In: Rosette, J.J.d., Sternberg, C.N., Poppel, H.P.v. (eds) Renal Cell Cancer. Springer, London. https://doi.org/10.1007/978-1-84628-763-3_43
Download citation
DOI: https://doi.org/10.1007/978-1-84628-763-3_43
Publisher Name: Springer, London
Print ISBN: 978-1-84628-385-7
Online ISBN: 978-1-84628-763-3
eBook Packages: MedicineMedicine (R0)